DNA methylation and 28-year cardiovascular disease risk in type 1 diabetes: the Epidemiology of Diabetes Complications (EDC) cohort study

BACKGROUND: The potential for DNA methylation (DNAm) as an early marker for cardiovascular disease (CVD) and how such an association might differ by glycemic exposure has not been examined in type 1 diabetes, a population at increased CVD risk. We thus performed a prospective epigenome-wide associat...

Descripción completa

Detalles Bibliográficos
Autores principales: Miller, Rachel G., Mychaleckyj, Josyf C., Onengut-Gumuscu, Suna, Feingold, Eleanor, Orchard, Trevor J., Costacou, Tina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394855/
https://www.ncbi.nlm.nih.gov/pubmed/37533055
http://dx.doi.org/10.1186/s13148-023-01539-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394855/
https://www.ncbi.nlm.nih.gov/pubmed/37533055
http://dx.doi.org/10.1186/s13148-023-01539-0

Ejemplares similares